Detailed Mechanism Funding and Narrative

Years of mechanism: 2008 2009

Details for Mechanism ID: 390
Country/Region: Kenya
Year: 2009
Main Partner: Management Sciences for Health
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $3,370,000

Funding for Care: TB/HIV (HVTB): $470,000

ACTIVITY UNCHANGED FROM COP 2008

1. LIST OF RELATED ACTIVITIES

This activity relates to activities in HIV Treatment: ARV drugs and Laboratory Infrastructure.

2. ACTIVITY DESCRIPTION.

The USAID funded Strengthening Pharmaceutical Systems Project (SPS), implemented by Management

Sciences for Health, will continue to strengthen, improve and maintain the national logistics and distribution

system for HIV clinical care, support and the prevention of TB. Through system strengthening, training and

monitoring, the National Leprosy and Tuberculosis Program (NLTP) will be enabled to improve case

detection rates, establish Diagnostic Counseling and Testing (DTC) and provide integrated TB/HIV

treatment and referral. Under the KEMSA support, SPS will continue supporting Central NTLP and

peripheral NTLP activities and at the same time, develop plans to capacitate NTLP to assume key

administrative and operational activities. As with other MOH programs and services which have continued

to request technical support for quantification and forecasting, the NLTP has also expressed a need in

these areas. Specifically, NLTP would benefit from greater knowledge and skills in quantification and

forecasting so as to move away from annual historical projections for commodities that contribute to

perennial stock outs and/or over supply. In view of the relatively high rate of HIV/TB co-infection a national

level, an integrated approach to HIV commodities procurement and management will be enhanced in order

to provide a fully integrated TB/HIV service at provincial and district level.

2. CONTRIBUTIONS TO OVERALL PROGRAM AREA

This activity will support the distribution and logistics systems for equipment, supplies and training

necessary to implement the National TB program for integrated TB/HIV activities. Targets for patients

treated as a result of these activities are listed under the activities funded through the NLTP and other

partners collaborating in the implementation of integrated TB/HIV activities.

3. LINKS TO OTHER ACTIVITIES

This activity also relates to activities in ARV drugs and Laboratory Infrastructure, which concentrate on

improving logistics for the various HIV/AIDS related commodities.

4. POPULATIONS BEING TARGETED

The main beneficiaries are people living with HIV/AIDS.

5. EMPHASIS AREAS

The major emphasis area for this component is logistics serving to enhance the availability of anti-TB drugs.

Minor areas of emphasis include quality assurance and support supervision and training.

New/Continuing Activity: Continuing Activity

Continuing Activity: 14923

Continued Associated Activity Information

Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds

System ID System ID

14923 8713.08 U.S. Agency for Management 6976 390.08 SPS $600,000

International Sciences for

Development Health

8713 8713.07 U.S. Agency for Management 4260 390.07 RPM/PLUS $1,400,000

International Sciences for

Development Health

Table 3.3.12:

Funding for Treatment: ARV Drugs (HTXD): $2,000,000

ACTIVITY UNCHANGED FROM COP 2008

1. LIST OF RELATED ACTIVITIES This activity relates to HLAB and TB/HIV services implemented by

MSH/SPS, the ARV procurement contract to be awarded by USAID through a mission competitive

procurement and HLAB , MTCT and HVCT activities by SCMS.

2. ACTIVITY DESCRIPTION

The USAID funded Strengthening Pharmaceutical Services Project (SPS), implemented by Management

Sciences for Health (MSH) will provide technical assistance in commodity management to KEMSA,

NASCOP and the Department of Pharmaceutical Services to strengthen commodity supply chain systems

supporting ART and other medical and pharmaceutical commodities related to HIV/AIDS. To assist in

capacity building for commodity management, SPS will continue to implement curricula for training ART

healthcare workers at all levels of care. SPS will also strengthen systems by developing and applying

Standard Operating Procedures for commodity management tools. In the 2009 COP implementation period,

SPS will continue to work directly with KEMSA and its staff at the Logistics Management Unit (LMU) in order

to support their activities that were previously supported under the MSH/RPM+ project. This includes

managing the LMIS system of parallel commodities. During COP 2009 period, this database that has been

maintained by MSH/SPS for some time now and has facilitated distribution of reports to relevant divisions

and agencies on stock status, will be transitioned to, mainstreamed and maintained by KEMSA. When this

transition happens, it will entail: expansion of the LMIS database to include all products warehoused and

distributed by KEMSA, finalization of the LMIS user manual, training KEMSA and users from MOH

departments (NASCOP, KEPI, RH, NLTP and essential drug programs) on how to use the LMIS and

implementing facility based forms and tools for recording and summarizing commodity usage data. This

component is part of the continued development of the national medical and pharmaceutical supply chain

system that distributes ARVs and other medical and pharmaceutical commodities from the national

warehouses to district warehouses and points of service. Over 400 points of service - public, private,

mission and NGO are served by this system. SPS will work with key partners to update product selection

according to MOH standard treatment guidelines, verify registration status, quantify requirements and

update forecasts to enable uninterrupted procurement. The LMIS system will enable timely and accurate

collection and reporting of ARV drug and other commodities to the National AIDS and STD Control Program

(NASCOP), KEMSA, the new USAID ARV procurement contractor, divisions of the MOH, and other

partners. These integrated activities will be jointly funded with non-HIV/AIDS funds to support the entire

national procurement and distribution system, with a key emphasis on reliable distribution of HIV/AIDS

commodities down to the "last mile." Key partners with whom SPS will work include: KEMSA, the Kenya

Government organization responsible for procuring and distributing medical supplies to government facilities

and currently responsible for distribution of all pharmaceuticals procured with resources from the

Government of Kenya and the Global Fund, the Supply Chain Management System contract (SCMS), the

major procurement and distribution partner of PEPFAR, and the National AIDS and STD Control Program

(NASCOP), the program with overall responsibility for management of the GOK program. SPS will also work

with the Department of Pharmaceutical Services and its institutions to support the policy and practice reform

agenda aimed at strengthening national skills and capacity in commodity selection, quantification,

procurement, distribution, quality assurance and appropriate use of commodities needed for the treatment

and care of PLWHA. SPS will also support activities by the pharmacy professional associations, the

NGO/private sector aimed at improving access and use of ARVs and other medicines in support of the

national ART programme. These will include implementation of the revised National Drug Policy to include

components supportive of the provision of effective ART commodity management services; preparation of

the national strategic plan to guide the pharmaceutical sub-sector; implementation of the Strategic Plan for

Pharmaceuticals services, support to stakeholders in the development and dissemination of various ART

policy guidelines; and advocacy for linkages between the Department of Pharmaceutical Services,

NASCOP, PPB , KEMSA, NQCL in cross-cutting issues such pharmaco-vigilance, ART drug procurement

and Quality Assurance. At site level, SPS will continue to provide technical assistance in the development

and adaptation of SOPs and forms; use of inventory management tools for patient medication counseling

for adherence; commodity management M&E systems, including Drug Utilization Reviews (DUR); the

design and implementation of ART Drug Management Information Systems; and training and monitoring for

performance improvement at site level employing the MTP methodology.

3. CONTRIBUTIONS TO OVERALL PROGRAM AREA

These activities will support the establishment of a sustainable national supply chain system capable of

managing medical and pharmaceutical supplies right from product selection, registration through

procurement, storage, distribution and consumption reporting, in proportion to the national epidemic.

4. POPULATIONS TARGETTED

The main populations targeted are people living with HIV/AIDS, health workers in the public sector and

MOH policymakers and managers.

5. EMPHASIS AREAS

The major emphasis area is systems strengthening of the public procurement and supply chain. Minor

emphasis areas are logistics, QA/QI and Training.

New/Continuing Activity: Continuing Activity

Continuing Activity: 14924

Continued Associated Activity Information

Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds

System ID System ID

14924 4209.08 U.S. Agency for Management 6976 390.08 SPS $4,000,000

International Sciences for

Development Health

6989 4209.07 U.S. Agency for Management 4260 390.07 RPM/PLUS $3,200,000

International Sciences for

Development Health

4209 4209.06 U.S. Agency for Management 3243 390.06 RPM/PLUS $1,800,000

International Sciences for

Development Health

Table 3.3.15:

Funding for Laboratory Infrastructure (HLAB): $900,000

ACTIVITY UNCHANGED FROM COP 2008

SECONDARY CROSS-CUTTING BUDGET ATTRIBUTIONS

This activity will support human capacity development through training.

COP 2008

+ Other (NON-SUBSTANTIVE) change will include the following:

MSH will assist in the implementation of the national Lab policy and strategy particularly regarding local

performance standards for labs. In addition MSH will provide support to the local accreditation of peripheral

labs assisting in classifying labs that are suitable to provide support to HIV patients.

1. LIST OF RELATED ACTIVITIES

This activity is related to the HVTB activity.

2. ACTIVITY DESCRITION

This activity will involve supporting the Ministries of Health through NPHLS and NASCOP to improve quality

management systems through coordination of trainings, work shops and seminars to develop national

policies and improve laboratory practices. Existing laboratory management information systems (MIS) will

be strengthened. Standard Operating Procedures (SOPs) for quality and efficiency of laboratory services

and job aids for Good Laboratory Practices (GLP) will be developed. The management and coordination of

the laboratory network will be strengthened. RPM Plus will provide technical assistance to strengthen

laboratory services in support of ART by working synergistically with the Laboratory ICC and other

stakeholders. All RPM Plus laboratory activities will be conducted under the auspices of the NPHLS. This

includes support for national-level activities such as those mentioned above as well as the implementation

of the national laboratory policy; implementation of a national laboratory policy strategic plan; and

development of institutional capacity by institutionalizing laboratory SOPs. RPM Plus will also support

NPHLS activities aimed at strengthening and scaling up laboratory activities at priority ART sites. Activities

include: refurbishment of priority laboratories (including the proposed Central Microbiology laboratory at the

NPHLS), facilitating training laboratory staff in skills for ART, SOPs and good laboratory practices such as

improved handling, transportation of specimens and return of results as well as universal precautions, and

improved laboratory record keeping and MIS. In addition, this project will assist laboratories by providing

guidance on the ART policy, professional and operational information and materials as needed; developing

SOPs on equipment maintenance, and strengthening sites to implement internal and external quality

assurance procedures. The project will also provide support to laboratory supervisors to strengthen their

management and coordination of laboratory services (supervisory check lists, job aids, monitoring tools,

operational planning guides), and will help institutionalize laboratory quality assurance procedures including

performance of internal quality controls (QCs) and calibration of equipment; training on the laboratory MIS,

monitoring and evaluation (M&E) tools and the use of routine laboratory data. MSH/SPS will closely

collaborate with NASCOP, NPHLS, KEMRI, CDC, KEMSA, UON, AMREF, FHI KMTC, AKMLSO, KMLTTB,

CDC, JSI, Clinton Foundation, USG HIV care and support grantees, private sector organizations and other

stakeholders comprising the National Laboratory Inter-agency Coordinating Committee (ICC).

3. CONTRIBUTIONS TO OVERALL PROGRAM AREA

This activity will result in improving access and use of quality diagnostic laboratory services through

improved training and capacity building, laboratory policies and management, including use of SOPs and

implementation of QA/QC systems.

4. LINKS TO OTHER ACTIVITIES

This activity links to the HVTB activity.

5. POPULATIONS TARGETED

The populations targeted are laboratory technicians at priority Ministry of Health ART centers, and

policymakers and division heads in the MOH.

6. EMPHASIS AREAS The main emphasis area is Training, with minor emphases on Strategic Information

and QA/QI/SS.

New/Continuing Activity: Continuing Activity

Continuing Activity: 14925

Continued Associated Activity Information

Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds

System ID System ID

14925 4210.08 U.S. Agency for Management 6976 390.08 SPS $900,000

International Sciences for

Development Health

6990 4210.07 U.S. Agency for Management 4260 390.07 RPM/PLUS $1,550,000

International Sciences for

Development Health

4210 4210.06 U.S. Agency for Management 3243 390.06 RPM/PLUS $700,000

International Sciences for

Development Health

Emphasis Areas

Health-related Wraparound Programs

* Child Survival Activities

* Malaria (PMI)

* Safe Motherhood

* TB

Workplace Programs

Human Capacity Development

Estimated amount of funding that is planned for Human Capacity Development $500,000

Public Health Evaluation

Food and Nutrition: Policy, Tools, and Service Delivery

Food and Nutrition: Commodities

Economic Strengthening

Education

Water

Table 3.3.16:

Cross Cutting Budget Categories and Known Amounts Total: $500,000
Human Resources for Health $500,000